The Reality of Puerto Rico after Maria
Big Pharma Provides Resilience and Hope
Top 10 Under 40
Biopharma Research and Businesses Benefit from Contributions of Emerging Leaders
Mass Spec Is Being Souped Up to Help It Keep Up
A Few Modifications Might Enhance Performance
GEN Roundup: Modular Proofs of Flexible Bioprocessing
In Combination, Prefab Unit Operations Can Accommodate Diverse Product Lines and Meet Shifting Capacity Demands
For full access to this article login to GEN Select now.
Systems Biology Alters Drug Development
Omics Tools Revitalize Field, but Deciphering High-throughput Data Is Still a Major Obstacle
- Research and development costs by pharmaceutical companies rose to an estimated $55.2 billion in 2006, with costs to develop a biologic drug reaching $1.2 billion. The potential of the Human Genome Project has yet to be fully realized, but many companies are starting to embrace systems biology as a ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.